Final report of University Hospital Hradec Kralove to the clinical trial protocol no. 115524

Abstract

Provedení části klinického hodnocení s názvem Immunogenicity and safety of meningococcal vaccine GSK 134612 GSK Biologicals at-risk subjects 1 to 18 years

Keywords

• meningococcus
• Vaccine GSK 134612
• imunogenicity and vaccine safety